{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "60290-025",
      "generic_name": "Olmesartan Medoxomil and Hydrochlorothiazide",
      "labeler_name": "Umedica Laboratories USA Inc.",
      "brand_name": "Olmesartan Medoxomil and Hydrochlorothiazide",
      "active_ingredients": [
        {
          "name": "OLMESARTAN MEDOXOMIL",
          "strength": "40 mg/1"
        },
        {
          "name": "HYDROCHLOROTHIAZIDE",
          "strength": "12.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "60290-025-01",
          "description": "30 TABLET in 1 BOTTLE (60290-025-01)",
          "marketing_start_date": "20260215",
          "sample": false
        },
        {
          "package_ndc": "60290-025-02",
          "description": "90 TABLET in 1 BOTTLE (60290-025-02)",
          "marketing_start_date": "20260215",
          "sample": false
        },
        {
          "package_ndc": "60290-025-03",
          "description": "1000 TABLET in 1 BOTTLE (60290-025-03)",
          "marketing_start_date": "20260215",
          "sample": false
        },
        {
          "package_ndc": "60290-025-04",
          "description": "100 TABLET in 1 BLISTER PACK (60290-025-04)",
          "marketing_start_date": "20260215",
          "sample": false
        },
        {
          "package_ndc": "60290-025-05",
          "description": "500 TABLET in 1 BOTTLE (60290-025-05)",
          "marketing_start_date": "20260215",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "5cace214-8690-0a8c-e063-6394a90a4c47",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260215",
      "product_id": "60290-025_5cace214-8690-0a8c-e063-6394a90a4c47",
      "application_number": "ANDA208847",
      "brand_name_base": "Olmesartan Medoxomil and Hydrochlorothiazide",
      "pharm_class": [
        "Angiotensin 2 Receptor Antagonists [MoA]",
        "Angiotensin 2 Receptor Blocker [EPC]",
        "Increased Diuresis [PE]",
        "Thiazide Diuretic [EPC]",
        "Thiazides [CS]"
      ]
    }
  ]
}